Osaic Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Sell |
27,839
-16,306
| -37% | -$124K | ﹤0.01% | 3557 |
|
|
2025
Q1 | $331K | Buy |
44,145
+15,976
| +57% | +$120K | ﹤0.01% | 3217 |
|
|
2024
Q4 | $212K | Buy |
28,169
+14,953
| +113% | +$112K | ﹤0.01% | 3541 |
|
|
2024
Q3 | $100K | Buy |
13,216
+7,699
| +140% | +$58.5K | ﹤0.01% | 4211 |
|
|
2024
Q2 | $34.1K | Sell |
5,517
-745,177
| -99% | -$4.61M | ﹤0.01% | 4946 |
|
|
2024
Q1 | $3.81M | Buy |
750,694
+57,665
| +8% | +$293K | 0.01% | 1226 |
|
|
2023
Q4 | $4.15M | Buy |
693,029
+43,711
| +7% | +$262K | 0.01% | 1330 |
|
|
2023
Q3 | $4.6M | Buy |
649,318
+46,229
| +8% | +$327K | 0.01% | 1363 |
|
|
2023
Q2 | $4.25M | Buy |
603,089
+41,028
| +7% | +$289K | 0.01% | 1299 |
|
|
2023
Q1 | $4.69M | Sell |
562,061
-5,857
| -1% | -$48.8K | 0.01% | 1202 |
|
|
2022
Q4 | $6.52M | Sell |
567,918
-5,659
| -1% | -$65K | 0.01% | 943 |
|
|
2022
Q3 | $7.23M | Sell |
573,577
-13,230
| -2% | -$167K | 0.02% | 811 |
|
|
2022
Q2 | $6.21M | Buy |
586,807
+12,558
| +2% | +$133K | 0.01% | 912 |
|
|
2022
Q1 | $9.34M | Buy |
574,249
+13,750
| +2% | +$224K | 0.02% | 793 |
|
|
2021
Q4 | $7.76M | Buy |
560,499
+51,030
| +10% | +$707K | 0.01% | 868 |
|
|
2021
Q3 | $7.32M | Buy |
509,469
+93,624
| +23% | +$1.35M | 0.02% | 824 |
|
|
2021
Q2 | $6.58M | Buy |
415,845
+27,148
| +7% | +$429K | 0.01% | 885 |
|
|
2021
Q1 | $3.95M | Buy |
388,697
+73,863
| +23% | +$751K | 0.01% | 1100 |
|
|
2020
Q4 | $2.35M | Buy |
314,834
+150,241
| +91% | +$1.12M | 0.01% | 1320 |
|
|
2020
Q3 | $565K | Buy |
164,593
+65,746
| +67% | +$226K | ﹤0.01% | 2321 |
|
|
2020
Q2 | $471K | Buy |
98,847
+73,124
| +284% | +$348K | ﹤0.01% | 2393 |
|
|
2020
Q1 | $51K | Buy |
+25,723
| New | +$51K | ﹤0.01% | 3938 |
|